1. Home
  2. CCK vs PRAX Comparison

CCK vs PRAX Comparison

Compare CCK & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crown Holdings Inc.

CCK

Crown Holdings Inc.

HOLD

Current Price

$112.86

Market Cap

11.3B

Sector

Industrials

ML Signal

HOLD

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$322.00

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCK
PRAX
Founded
1906
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.3B
9.6B
IPO Year
2003
2020

Fundamental Metrics

Financial Performance
Metric
CCK
PRAX
Price
$112.86
$322.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
15
Target Price
$123.27
$572.13
AVG Volume (30 Days)
1.2M
371.8K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
0.90%
N/A
EPS Growth
79.72
N/A
EPS
6.38
N/A
Revenue
$11,665,000,000.00
N/A
Revenue This Year
$5.03
N/A
Revenue Next Year
$2.53
$1,840.20
P/E Ratio
$18.21
N/A
Revenue Growth
N/A
N/A
52 Week Low
$75.98
$26.70
52 Week High
$116.62
$354.87

Technical Indicators

Market Signals
Indicator
CCK
PRAX
Relative Strength Index (RSI) 54.28 50.06
Support Level $94.24 $290.36
Resistance Level $116.24 $322.32
Average True Range (ATR) 2.57 19.02
MACD -0.21 -2.10
Stochastic Oscillator 45.66 46.86

Price Performance

Historical Comparison
CCK
PRAX

About CCK Crown Holdings Inc.

Crown Holdings is one of the world's largest producers of metal packaging. The company manufactures beverage cans, metal food cans, and closures as well as aerosol cans. With the purchase of Signode, the company also has a presence in a wide variety of protective transport packaging. Although it's headquartered in the United States, the vast majority of Crown's sales come from its operations in Europe, South America, and Southeast Asia.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: